Paperpal Prime Logo

Expert Opinion on Drug Metabolism and Toxicology : Impact Factor & More

eISSN: 1744-7607pISSN: 1742-5255

Aims and Scope of Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio (Food and Drug Administration). Less

Key Metrics

CiteScore
7.2
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Toxicology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism and Toxicology Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Metabolism and Toxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Metabolism and Toxicology

GLP-1RA pharmacokinetics and clinical effects: focus on cardiac, vascular, and glomerular structures
  • 9 Aug 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation.
  • 8 Aug 2026
  • Expert opinion on drug metabolism & toxicology
Quantitative systems pharmacology of HIV PrEP and PEP
  • 3 Aug 2026
  • Expert Opinion on Drug Metabolism & Toxicology
The use of natural language processing in predictive toxicology
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Drug-drug interactions in patients living with HIV and major depression
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
GLP-1RA pharmacokinetics and clinical effects: focus on cardiac, vascular, and glomerular structures
  • 9 Aug 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation.
  • 8 Aug 2026
  • Expert opinion on drug metabolism & toxicology
Quantitative systems pharmacology of HIV PrEP and PEP
  • 3 Aug 2026
  • Expert Opinion on Drug Metabolism & Toxicology
The use of natural language processing in predictive toxicology
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Drug-drug interactions in patients living with HIV and major depression
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology

FAQs on Expert Opinion on Drug Metabolism and Toxicology